PRESS RELEASE published on 02/28/2024 at 10:00, 2 years 5 months ago Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne and emphasises important contribution to patient care Prof Dr Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne, emphasizing vital contribution to patient care. Plasma donation in Germany crucial for medical supply Germany Patient Care Biotest AG Karl Lauterbach Plasma Donation
BRIEF published on 02/28/2024 at 10:00, 2 years 5 months ago Visit of Karl Lauterbach to the plasma donation center of Biotest AG in Cologne Germany Biotest AG Karl Lauterbach Plasma Donation Medical Care
PRESS RELEASE published on 02/14/2024 at 08:30, 2 years 5 months ago Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate. Study results confirm safety profile & effectiveness equal to standard care in reducing blood loss. Biotest aims to address global medical need with USD 800 million market potential Biotest AG Fibrinogen Concentrate Phase III Trial Study Results Medical Market Potential
PRESS RELEASE published on 11/28/2023 at 09:00, 2 years 8 months ago EQS-News: Biotest’s Trimodulin shows reduced mortality in patients with severe community-acquired pneumonia through rapid normalisation of inflammation
PRESS RELEASE published on 11/02/2023 at 08:00, 2 years 9 months ago Biotest increases EBIT to Euro 125.4 million in the first nine months of 2023
PRESS RELEASE published on 10/05/2023 at 16:55, 2 years 10 months ago EQS-Adhoc: Biotest AG: Increase of the EBIT guidance
PRESS RELEASE published on 10/05/2023 at 16:42, 2 years 10 months ago EQS-Adhoc: Biotest AG: Peter Janssen appointed new Chairman of the Board of Biotest AG
PRESS RELEASE published on 09/21/2023 at 09:00, 2 years 10 months ago Biotest AG: Biotest receives approval for innovative immunoglobulin Yimmugo® in the UK
PRESS RELEASE published on 09/12/2023 at 09:00, 2 years 11 months ago Biotest AG: Biotest treats first patient with severe community-acquired pneumonia in phase III trial with trimodulin
PRESS RELEASE published on 09/07/2023 at 09:00, 2 years 11 months ago Biotest AG: US Food and Drug Administration FDA accepts marketing authorization application for immunoglobulin Yimmugo
Published on 08/12/2026 at 11:30, 20 minutes ago American Critical Minerals Announces the Execution of the Drilling Contract with Drake Well Service and Mobilization to the Green River Project
Published on 08/12/2026 at 09:01, 2 hours 49 minutes ago Apex Drills 4.48% REO Over 8.0 m and 5.27% REO Over 10.2 m Within Multiple ~ 150 m Intervals of > 2.00 % REO at the Rift Rare Earth Project in SE Nebraska
Published on 08/12/2026 at 08:02, 3 hours 48 minutes ago Southern Energy Corp. Announces Spudding of Cotton Valley Test Well at Williamsburg and Appointment of Market Maker
Published on 08/12/2026 at 08:00, 3 hours 50 minutes ago Galantas Selects Engineering and Mine Planning Contractors for Andacollo Gold Project
Published on 08/12/2026 at 00:00, 11 hours 50 minutes ago Organto Foods Reports Record Second Quarter 2026 Financial Results
Published on 08/12/2026 at 11:47, 2 minutes ago SME bond market H1 2026: Issuance activity picks up, placement becomes more challenging
Published on 08/12/2026 at 11:31, 18 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 08/12/2026 at 11:29, 20 minutes ago EQS-Adhoc: Valour Digital Securities Limited: Compulsory Redemption by the Issuer
Published on 08/12/2026 at 11:24, 25 minutes ago EQS-Adhoc: STEICO SE: Aiveen Kearney steps down as CEO - Thorsten Leicht appointed Chairman of the Managing Directors (CEO)
Published on 08/10/2026 at 18:00, 1 day 17 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 11:53, 1 day 23 hours ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 2 days ago GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 2 days 2 hours ago Number of shares and voting rights - July 2026 (In French only)